TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ÀüÁ¦Ç°º¸±â > Genome Editing > Overivew > Customer data for Guide-it¢â products
Guide-it¢â °í°´ÀÇ ½ÇÁ¦ ½ÇÇèµ¥ÀÌÅÍ

Customer data for Guide-it¢â products

-

CRISPR/Cas9Àº À¯ÀüÀÚ ÆíÁý ¹× ±â´É ºÐ¼®À» À§ÇÑ Çõ½ÅÀûÀÎ ±â¼ú·Î, ´ÙÄ«¶ó°¡ Á¦°øÇÏ´Â Guide-it¢â Á¦Ç°Àº º¸´Ù È¿À²ÀûÀÌ°í ¿ëÀÌÇÑ CRISPR À¯ÀüÀÚ ÆíÁý ½ÇÇèÀ» µµ¿Íµå¸³´Ï´Ù. ÀÌ¹Ì ¸¹Àº °í°´µéÀÌ Guide-it¢â Á¦Ç°À» »ç¿ëÇÏ¿© ÁÁÀº ½ÇÇè µ¥ÀÌÅ͸¦ ¾ò¾ú´Âµ¥¿ä. ¿Ö ¿¬±¸ÀÚµéÀÌ Guide-it¢â CRISPR/Cas9 Á¦Ç°À» ¼±ÅÃÇß´ÂÁö ÇÔ²² º¸½ÃÁÒ!

1. Optimizing a screen for high-efficiency guide RNAs
Dr. Manabu Toyoshima (The Molecular Psychiatry team at the RIKEN Brain Science Institute)


Introduction
Manabu Toyoshima ¹Ú»ç´Â Á¶Çöº´°ú ¹ß´ÞÀå¾Ö ȯÀڷκÎÅÍ À¯·¡ÇÑ iPS ¼¼Æ÷¸¦ ÀÌ¿ëÇØ Áúº´ ¸ÞÄ¿´ÏÁò°ú ÀáÀçÀû Ä¡·á¹ýÀ» ±Ô¸íÇÏ°íÀÚ ÇÏ¿´´Ù. ÀÌ¿¡ Toyoshima ¹Ú»ç´Â °¡Àå ³ôÀº ÆíÁý È¿À²À» °¡Áø single guide RNAs (sgRNAs)¸¦ ¼±º°Çϱâ À§ÇÏ¿© ´ç»çÀÇ Guide-it¢â Complete sgRNA Screening SystemÀ» »ç¿ëÇÏ¿´´Ù.

Result
Human iPS ¼¼Æ÷ Áß ÇϳªÀÇ ¸ñÀû À¯ÀüÀÚ¸¦ Ÿ°ÙÇÏ´Â 5°³ÀÇ sgRNA¸¦ µðÀÚÀÎ ÈÄ, Guide-it¢â Complete sgRNA Screening SystemÀ» ÀÌ¿ëÇÏ¿© °¢ sgRNAÀÇ Àý´Ü È¿À²À» in vitro »ó¿¡¼­ È®ÀÎÇÏ¿´´Ù. °á°ú¿¡ µû¶ó °¡Àå È¿À²ÀÌ ³ôÀº 2°³ÀÇ sgRNA (No. 2 & No. 4)¸¦ Human iPS ¼¼Æ÷ÀÇ CRISPR Knock-out ½ÇÇè¿¡ »ç¿ëÇÏ¿´´Ù. ¶ÇÇÑ »ý¼ºµÈ º¯ÀÌ (Mutagenesis)´Â ´ç»çÀÇ Guide-it¢â Mutation Detection Kit·Î È®ÀÎÇÏ¿´´Ù.


±×¸² 1. Guide-it¢â Complete sgRNA Screening SystemÀ» ÀÌ¿ëÇÑ sgRNAÀÇ in vitro Àý´ÜÈ¿À².
sgRNA No.2¿Í No.4ÀÇ Àý´Ü È¿À²ÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î È®ÀεǾúÀ¸¸ç, ÀÌ µÎ °³ÀÇ sgRNA¸¦ iPS ¼¼Æ÷ À¯ÀüÀÚ ÆíÁý¿¡ È°¿ëÇÏ¿´´Ù.


±×¸² 2. Human iPS ¼¼Æ÷¿¡¼­ À¯ÀüÀÚ ÆíÁý È¿À².
Guide-it¢â Mutation Detection Kit¸¦ ÀÌ¿ëÇÏ¿© sgRNA No.2¿Í No.4ÀÇ À¯ÀüÀÚ ÆíÁý È¿À²À» È®ÀÎÇÏ¿´´Ù.

2. Electroporation of recombinant Cas9 in mouse embryos
Dr. Kazuki Nakao (University of Tokyo)


Introduction
Kazuki Nakao ¹Ú»ç´Â transgenic mouseÀÇ Ã¼¿Ü¼öÁ¤ (In vitro fertilization, IVF)°ú ³Ãµ¿º¸Á¸¹ý (cryopreservation)À» ÁÖ·Î ¿¬±¸ÇÏ°í ÀÖ´Ù. Nakao ¹Ú»ç´Â ÃÖ±Ù, ´ÙÄ«¶ó¿¡¼­ Á¦°øÇÏ´Â Guide-it¢â Recombinant Cas9 (Electroporation-Ready)ÀÌ Å¸»çÀÇ Cas9 ´Ü¹éÁú¿¡ ºñÇÏ¿© ¼º´ÉÀÌ º¸´Ù ¿ì¼öÇÔÀ» Áõ¸íÇÏ´Â µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿´´Ù.

Result
C57BL/6N mouse ¹è¾Æ¿¡¼­ tyrosinase locus ºÎÀ§¸¦ À¯ÀüÀÚ ÆíÁýÇϱâ À§ÇÏ¿© Guide-it¢â Recombinant Cas9 (Electroporation-Ready)À» ÀÌ¿ëÇÏ¿© electroporation ÇÏ¿´´Ù. 14.5ÀÏ·ÉÀÇ mouse žƸ¦ »ç¿ëÇÏ¿´°í, tyrosinase locusÀÇ À¯ÀüÀÚ ÆíÁý ¼º°ø·üÀº ¾Ëºñ³ë Ư¡À» º¸À̴ žÆÀÇ ¼ö·Î È®ÀÎÇÏ¿´´Ù.

Manufacturer

Cas9
concentration
(ng/¥ìl)

Number of embryos
subjected to
electroporation

Number of implanted
electroporated
embryos

Number
of fetuses

Number of
albino
fetuses

Takara Bio

25

60

60

12

9

100

60

60

7

7

Company A

25

60

60

13

2

100

60

60

23

12

400

40

40

7

4

Company B

25

60

59

22

0


Ç¥ 1. Guide-it¢â Recombinant Cas9 (Electroporation-Ready)°ú Ÿ »çÀÇ Cas9 ´Ü¹éÁúÀ» ÀÌ¿ëÇÑ tyrosinase À¯ÀüÀÚ ÆíÁýÀÇ °á°ú.
Takara BioÀÇ Guide-it¢â Recombinant Cas9Àº Ÿ»ç Á¦Ç°¿¡ ºñÇØ ³·Àº ±Û¸®¼¼·Ñ ³óµµ¸¦ º¸À¯ÇÏ°í ÀÖ¾î ¼¼Æ÷ µ¶¼ºÀÌ ³·À» »Ó¸¸ ¾Æ´Ï¶ó ³ôÀº À¯ÀüÀÚ ÆíÁý È¿À²À» º¸ÀδÙ. Guide-it¢â Recombinant Cas9ÀÇ À¯ÀüÀÚ ÆíÁý ¼º°ø·üÀº 25 ng/§¡ Cas9À» µµÀÔÇßÀ» ¶§ 75%, 100ng/§¡ Cas9À» µµÀÔÇßÀ» ¶§ 100%¸¦ º¸¿´´Ù. ÀÌ´Â A»çÀÇ Á¦Ç°, B»çÀÇ Á¦Ç°À» »ç¿ëÇÏ¿´À» ¶§º¸´Ù ¿ùµîÈ÷ ³ôÀº À¯ÀüÀÚ ÆíÁý È¿À²ÀÓÀ» È®ÀÎÇÏ¿´´Ù. (A»ç Á¦Ç°ÀÇ À¯ÀüÀÚ ÆíÁýÈ¿À²: 15%, 52%, 57% / B»ç Á¦Ç°ÀÇ À¯ÀüÀÚ ÆíÁýÈ¿À²: 0%)

3. Microinjection of recombinant Cas9 in mouse embryos


Introduction
Yuichi Hiraoka ¹Ú»ç¿Í µ¿·á ¿¬±¸ÀÚ´Â »õ·Î¿î transgenic mouse¸¦ °³¹ßÇÏ°í ¹ø½Ä½ÃÅ°´Â ¿¬±¸¸¦ ÁøÇàÇÏ°í ÀÖ´Ù. ±×µéÀº ÃÖ±Ù ³Ãµ¿µÈ Áã ¹è¾Æ¿¡ Guide-it¢â Recombinant Cas9 (Electroporation-Ready)À» microinjectionÇÏ¿© À¯ÀüÀÚ ÆíÁýÀ» ¼öÇàÇÏ¿´°í, Guide-it¢â Recombinant Cas9 (Electroporation-Ready)ÀÇ ¶Ù¾î³­ ÆíÁýÈ¿À²À» ±Ô¸íÇÏ´Â µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿´´Ù.
Result
C57BL/6 mouse embryo¿¡ Guide-it¢â Recombinant Cas9 (Electroporation-Ready)¿Í donor construct (Ç¥ 2 ÂüÁ¶)¸¦ microinjectionÇÏ¿© À¯ÀüÀÚ ÆíÁýÀ» À¯µµÇÏ¿´´Ù. À¯ÀüÀÚÆíÁýÀÇ ¼º°øÈ®·üÀº µµÀÔÇÑ À¯ÀüÀÚ¸¦ º¸À¯ÇÏ°í ÀÖ´Â »õ³¢ÀÇ ºñÀ²·Î È®ÀÎÇÏ¿´´Ù.

Gene
name

Type
(insertion cassette/deletion length)

Donor

Litter size

Pups containing
modification

Efficiency

Gene A

Insert (length: 3 kb)

Plasmid

9

4

44%

Gene B

Insert (length: 7.5 kb)

Plasmid

11

4

36%

Gene C

Knockout (deletion length: 51 kb)

Oligo DNA donor

14

4

28%

Gene D

SNP

Oligo DNA donor

8

2

25%

Gene E

Flox

Plasmid

6

2

33%

Gene F

Flox

Plasmid

8

2

25%